{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:12:05Z","timestamp":1777975925710,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Carpal Tunnel Syndrome (CTS) is a common peripheral neuropathy, and\nimmune dysregulation and microbial dysbiosis are believed to play a role in its development. However, the cause-and-effect relationships have yet to be clarified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using publicly available Genome-Wide Association Study (GWAS), there are 731 immune cell phenotypes, 91 inflammatory proteins, 150 skin microbiota taxon, and 473 gut microbiota taxon based on 2-sample Mendelian Randomization (MR) analysis to test whether there is a\ncausal relationship between them and CTS. The results from the study were shown to have some\ndegree of stability as demonstrated by various sensitivity analyses, which included running heterogeneity tests, performing MR -PRESSO, and running MR-Egger regressions. On the other hand,\nreverse MR was performed to verify the direction of the association. In addition, a two-step MR\nmediation analysis was conducted to explore whether there was a mediation effect of gut microbiota and skin microbiota, respectively, of immune and inflammatory traits on CTS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>22 Immune cell traits, 4 Inflammatory proteins, 18 gut microbiota taxa, and 3 skin microbiota taxa are causally associated with CTS. Reverse MR suggested feedback effects of CTS on select immune traits and gut microbiota. Mediation analysis revealed 4 gut microbiota taxa that substantially mediated immune\/inflammatory effects upon CTS, with mediation rates as high as 44%;\nhowever, skin microbiota did not demonstrate any mediation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The immune dysregulation, inflammation, and the gut microbiota that cause Carpal\nTunnel Syndrome (CTS) are all revealed through this research. Mendelian randomization analysis\nsuggests that traits and inflammatory proteins of immune cells directly increase the risk of CTS,\nand certain types of gut microbes partially mediate these effects. Therefore, the results show a central role of the immune-gut axis in CTS pathogenesis, and suggest a systemic, rather than a local,\nimmune-microbial interaction in disease development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We provided the first causal evidence that immune cells, inflammatory proteins, and\nCTS risk are causally associated with some specific taxa of gut microbiota. This contributes to a\nbetter understanding of the immune-microbiome interactions in the process of occurrence and development of CTS, and also provides theoretical support for precision prevention and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715303452467260416073725","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:24:51Z","timestamp":1777973091000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunological, Inflammatory, and Microbiota\nDeterminants of Carpal Tunnel Syndrome:\nEvidence from Mendelian Randomization"],"prefix":"10.2174","volume":"26","author":[{"given":"Zeyu","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Chengde Medical College, Chengde, Hebei Province, China"},{"name":"Hebei Key Laboratory of Panvascular Diseases, Chengde, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwei","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Chengde Medical College, Chengde, Hebei Province, China"},{"name":"Hebei Key Laboratory of Panvascular Diseases, Chengde, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenghui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Immunology, Mudanjiang Medical University, Mudanjiang, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoni","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Chengde Medical College, Chengde, Hebei Province, China"},{"name":"Hebei Key Laboratory of Panvascular Diseases, Chengde, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Chengde Medical College, Chengde, Hebei Province, China"},{"name":"Hebei Key Laboratory of Panvascular Diseases, Chengde, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715303452467260416073725","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/253214\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715303452467260416073725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:25:15Z","timestamp":1777973115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/253214\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715303452467260416073725","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}